Northern Trust’s Boundless Bio BOLD Stock Holding History

Northern Trust’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.1K	Buy	+34,824	New	+$53.6K	﹤0.01%	4156
2026 Q1	–	Sell	-189,475	Closed	-$227K	–	4551
2025 Q4	$227K	Sell	189,475 -1,326	-0.7%	-$1.65K	﹤0.01%	3936
2025 Q3	$235K	Sell	190,801 -16,699	-8%	-$19.3K	﹤0.01%	3925
2025 Q2	$210K	Sell	207,500 -107,865	-34%	-$143K	﹤0.01%	3921
2025 Q1	$476K	Buy	315,365 +217,353	+222%	+$451K	﹤0.01%	3591
2024 Q4	$284K	Buy	98,012 +40,434	+70%	+$118K	﹤0.01%	3868
2024 Q3	$200K	Buy	+57,578	New	+$209K	﹤0.01%	3896

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Northern Trust's BOLD Position: Q2 2026 in Review

Northern Trust opened a new position in Boundless Bio (BOLD) in Q2 2026: 34,824 shares worth $87.1K. The stake represents ﹤0.01% of the portfolio and ranks #4156 among its holdings. This is a return to the name: Northern Trust previously reported a position in BOLD as recently as Q4 2025.

Northern Trust first reported a position in BOLD in Q3 2024 and has held it in 7 quarters since. The position peaked at $476K in Q1 2025. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Northern Trust held 34,824 shares of Boundless Bio worth $87.1K as of Q2 2026.
Boundless Bio was a new Northern Trust position in Q2 2026.
Boundless Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4156 holding.
Northern Trust first reported a position in Boundless Bio in Q3 2024 and has held it in 7 quarters since.
Northern Trust's Boundless Bio position peaked at $476K in Q1 2025.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.